ConductScience.org, home

Paper6134820

Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292.

Smith HJ and 3 others. J Pharmacol Exp Ther, 1983. Cited by 36 papers, by iCite.

Cite this record

ConductScience Library. Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292. Papers, record 6134820. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6134820

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292.
PubMed
Journal
J Pharmacol Exp Ther
PubMed
Year
1983
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
2.3
iCite
Revised in PubMed
2016-11-23
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Smith HJH J
2Halliday SES E
3Earl DCD C
4Stribling DD

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AntagonistsMajor topic
BenzeneacetamidesMajor topic
HemodynamicsMajor topic
IsoproterenolMajor topic
PropanolaminesMajor topic
Animals
Atenolol
Blood Glucose
Blood Pressure
Dogs
Fatty Acids, Nonesterified
Heart Rate
Insulin
Lactates
Lactic Acid
Male
Propranolol

Source PubMed

Download CSV of topics

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
17242933Myocardial lactate deprivation is associated with decreased cardiovascular performance, decreased myocardial energetics, and early death in endotoxic shock.Intensive Care Med2007https://conductscience.org/library/papers/17242933PubMed
8395198
Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
Cardiovasc Drugs Ther1993https://conductscience.org/library/papers/8395198PubMed
8097925
Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.
Cardiovasc Drugs Ther1993https://conductscience.org/library/papers/8097925PubMed
7918133Acute systemic and antiischemic effects of epanolol in patients with coronary artery disease.Cardiovasc Drugs Ther1994https://conductscience.org/library/papers/7918133PubMed
7915237The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease.Eur J Clin Pharmacol1994https://conductscience.org/library/papers/7915237PubMed
6152175Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patients.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6152175PubMed
3533563Assessment of the relative safety of the beta-blockers ICI 141,292 and atenolol in patients with bronchial asthma.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3533563PubMed
2887189Post-exercise hypotension: the effects of epanolol or atenolol on some hormonal and cardiovascular variables in hypertensive men.Br J Clin Pharmacol1987https://conductscience.org/library/papers/2887189PubMed
2883987Effects of beta-adrenoceptor blockade on heart rate and physiological tremor in diabetics with autonomic neuropathy. A comparative study of epanolol, atenolol and pindolol.Br J Clin Pharmacol1987https://conductscience.org/library/papers/2883987PubMed
2883003Effects on physical performance of intrinsic sympathomimetic activity (ISA) during selective beta 1-blockade.Eur J Appl Physiol Occup Physiol1987https://conductscience.org/library/papers/2883003PubMed
2880603
Immediate haemodynamic effects of a novel partial agonist, beta 1-adrenoceptor blocking drug ICI 141,292 after intravenous administration to healthy young volunteers and patients with ischaemic heart disease.
Br J Clin Pharmacol1987https://conductscience.org/library/papers/2880603PubMed
2870732Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.Br J Clin Pharmacol1986https://conductscience.org/library/papers/2870732PubMed
2869814Central beta-adrenoceptors can modulate 5-hydroxytryptamine-induced tremor in rats.Br J Pharmacol1986https://conductscience.org/library/papers/2869814PubMed
2864052Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function.Br J Clin Pharmacol1985https://conductscience.org/library/papers/2864052PubMed
2575978Dose finding in angina--results with epanolol.Drugs1989https://conductscience.org/library/papers/2575978PubMed
2575977Epanolol. A new once-daily antianginal agent: dose finding and long term efficacy.Drugs1989https://conductscience.org/library/papers/2575977PubMed
2575976Clinical pharmacology of epanolol. Pharmacodynamic aspects.Drugs1989https://conductscience.org/library/papers/2575976PubMed
1976342Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?Br J Clin Pharmacol1990https://conductscience.org/library/papers/1976342PubMed
1685667The effects of selective beta-adrenoceptor antagonists and partial agonist activity on renal function during exercise in normal subjects and those with moderate renal impairment.Br J Clin Pharmacol1991https://conductscience.org/library/papers/1685667PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6134820

GET https://conductscience.org/api/papers/v1/6134820/authors